Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-24-000043

Chief Executive Officer returned 9,727 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Virnich Daniel · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-20 Returned to the company : show line 1 in the form −4,750 $0.14 $646 716,961 D
2024-11-20 Returned to the company : show line 2 in the form −4,977 $0.14 $677 711,984 D
Loading xslF345X05/wk-form4_1732231374.xml…